Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Penumbra Inc (PEN)

Penumbra Inc (PEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Penumbra Inc One Penumbra Place Alameda CA 94502 USA

www.penumbrainc.com Employees: 4,500 P: 510-748-3200

Sector:

Medical

Description:

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.

Key Statistics

Overview:

Market Capitalization, $K 13,341,706
Enterprise Value, $K 13,017,306
Shares Outstanding, K 39,162
Float, K 37,517
% Float 95.80%
Short Interest, K 1,602
Short Float 4.09%
Days to Cover 1.00
Short Volume Ratio 0.65
% of Insider Shareholders 4.20%
% of Institutional Shareholders 88.88%

Financials:

Annual Sales, $ 1,195 M
Annual Net Income, $ 14,010 K
Last Quarter Sales, $ 354,690 K
Last Quarter Net Income, $ 45,850 K
EBIT, $ 172,800 K
EBITDA, $ 196,500 K

Growth:

1-Year Return 12.43%
3-Year Return 27.41%
5-Year Return 19.78%
5-Year Revenue Growth 118.23%
5-Year Earnings Growth 126.53%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.97 on 11/05/25
Next Earnings Date 02/17/26
Earnings Per Share ttm 3.63
EPS Growth vs. Prev Qtr 12.79%
EPS Growth vs. Prev Year 14.12%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PEN Ratios

Ratio
Price/Earnings ttm 94.03
Price/Earnings forward 67.42
Price/Earnings to Growth 2.10
Return-on-Equity % 11.35%
Return-on-Assets % 8.70%
Profit Margin % 1.17%
Debt/Equity 0.00
Price/Sales 10.13
Price/Cash Flow 118.24
Price/Book 9.84
Book Value/Share 34.70
Interest Coverage -1.03
60-Month Beta 0.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar